Evidence map›Paper›PMID 10584089›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne1999

Drug-drug interactions: how scared should we be?

L E Shapiro, N H Shear

Abstract readCommentEditorial
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Potential for drug interactions in seniors with osteoarthritis.Canadian family physician Medecin de famille canadien · 2006
    Article
  11. Promising deliveries, delivering promises.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2002
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

L E Shapiro
N H Shear

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aryl Hydrocarbon HydroxylasesDrug-Related Side Effects and Adverse ReactionsPolypharmacySteroid 16-alpha-HydroxylaseAnticholesteremic AgentsCytochrome P-450 CYP3ACytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemDrug InteractionsDrug MonitoringEnzyme InhibitorsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMixed Function OxygenasesPharmaceutical PreparationsSteroid HydroxylasesAnticholesteremic AgentsAryl Hydrocarbon HydroxylasesCYP3A protein, humanCytochrome P-450 CYP3ACytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme SystemEnzyme InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsMixed Function OxygenasesPharmaceutical PreparationsSteroid 16-alpha-HydroxylaseSteroid Hydroxylases

Identifiers

PMID10584089
PMCPMC1230790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.